Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Clinical Efficacy and Safety Versus Biological...
Journal article

Clinical Efficacy and Safety Versus Biological Response of Desmopressin (DDAVP) In Inherited Von Willebrand Disease (VWD) Types 1 and 2: Initial Results From the International Study Group on DDAVP In VWD In a Cohort of 229 Patients

Abstract

Abstract Abstract 238

Authors

Federici AB; Iorio A; Castaman G

Journal

Blood, Vol. 116, No. 21,

Publisher

American Society of Hematology

Publication Date

November 19, 2010

DOI

10.1182/blood.v116.21.238.238

ISSN

0006-4971